Literature DB >> 24786567

In vivo applications of electrospun tissue-engineered vascular grafts: a review.

Kevin A Rocco1, Mark W Maxfield, Cameron A Best, Ethan W Dean, Christopher K Breuer.   

Abstract

There is great clinical demand for synthetic vascular grafts with improved long-term efficacy. The ideal vascular conduit is easily implanted, nonthrombogenic, biocompatible, resists aneurysmal dilatation, and ultimately degrades or is assimilated as the patient remodels the graft into tissue resembling native vessel. The field of vascular tissue engineering offers an opportunity to design the ideal synthetic graft, and researchers have evaluated a variety of methods and materials for use in graft construction. Electrospinning is one method that has received considerable attention within tissue engineering for constructing so-called tissue scaffolds. Tissue scaffolds are temporary, porous structures which are commonly composed of bioresorbable polymers that promote native tissue ingrowth and have degradation kinetics compatible with a patient's rate of extracellular matrix production in order to successfully transit from synthetic conduits into neovessels. In this review, we summarize the history of tissue-engineered vascular grafts (TEVG), focusing on scaffolds generated by the electrospinning process, and discuss in vivo applications. We review the materials commonly employed in this approach and the preliminary results after implantation in animal models in order to gauge clinical viability of the electrospinning process for TEVG construction. Scientists have studied electrospinning technology for decades, but only recently has it been orthotopically evaluated in animal models such as TEVG. Advantages of electrospun TEVG include ease of construction, favorable cellular interactions, control of scaffold features such as fiber diameter and pore size, and the ability to choose from a variety of polymers possessing a range of mechanical and chemical properties and degradation kinetics. Given its advantages, electrospinning technology merits investigation for use in TEVG, but an emphasis on long-term in vivo evaluation is required before its role in clinical vascular tissue engineering can be realized.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24786567     DOI: 10.1089/ten.TEB.2014.0123

Source DB:  PubMed          Journal:  Tissue Eng Part B Rev        ISSN: 1937-3368            Impact factor:   6.389


  46 in total

1.  Biomechanical Comparison of Glutaraldehyde-Crosslinked Gelatin Fibrinogen Electrospun Scaffolds to Porcine Coronary Arteries.

Authors:  E Tamimi; D C Ardila; D G Haskett; T Doetschman; M J Slepian; R S Kellar; J P Vande Geest
Journal:  J Biomech Eng       Date:  2016-01       Impact factor: 2.097

Review 2.  Progress in material design for biomedical applications.

Authors:  Mark W Tibbitt; Christopher B Rodell; Jason A Burdick; Kristi S Anseth
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-24       Impact factor: 11.205

3.  Improved cellular infiltration in electrospun fiber via engineered porosity.

Authors:  Jin Nam; Yan Huang; Sudha Agarwal; John Lannutti
Journal:  Tissue Eng       Date:  2007-09

4.  Computationally optimizing the compliance of multilayered biomimetic tissue engineered vascular grafts.

Authors:  Ehab Akram Tamimi; Diana Catalina Ardila; Burt D Ensley; Robert S Kellar; Jonathan Vande Geest
Journal:  J Biomech Eng       Date:  2019-02-19       Impact factor: 2.097

5.  Role of Bone Marrow Mononuclear Cell Seeding for Nanofiber Vascular Grafts.

Authors:  Takuma Fukunishi; Cameron A Best; Chin Siang Ong; Tyler Groehl; James Reinhardt; Tai Yi; Hideki Miyachi; Huaitao Zhang; Toshiharu Shinoka; Christopher K Breuer; Jed Johnson; Narutoshi Hibino
Journal:  Tissue Eng Part A       Date:  2017-06-13       Impact factor: 3.845

Review 6.  Textile Technologies and Tissue Engineering: A Path Toward Organ Weaving.

Authors:  Mohsen Akbari; Ali Tamayol; Sara Bagherifard; Ludovic Serex; Pooria Mostafalu; Negar Faramarzi; Mohammad Hossein Mohammadi; Ali Khademhosseini
Journal:  Adv Healthc Mater       Date:  2016-02-29       Impact factor: 9.933

7.  Cell layer-electrospun mesh composites for coronary artery bypass grafts.

Authors:  Josh D Erndt-Marino; Silvia Becerra-Bayona; Rebecca E McMahon; Aaron S Goldstein; Mariah S Hahn
Journal:  J Biomed Mater Res A       Date:  2016-05-04       Impact factor: 4.396

8.  Differential outcomes of venous and arterial tissue engineered vascular grafts highlight the importance of coupling long-term implantation studies with computational modeling.

Authors:  Cameron A Best; Jason M Szafron; Kevin A Rocco; Jacob Zbinden; Ethan W Dean; Mark W Maxfield; Hirotsugu Kurobe; Shuhei Tara; Paul S Bagi; Brooks V Udelsman; Ramak Khosravi; Tai Yi; Toshiharu Shinoka; Jay D Humphrey; Christopher K Breuer
Journal:  Acta Biomater       Date:  2019-06-12       Impact factor: 8.947

9.  Oversized Biodegradable Arterial Grafts Promote Enhanced Neointimal Tissue Formation.

Authors:  Cameron Best; Takuma Fukunishi; Joseph Drews; Ramak Khosravi; Kan Hor; Nathan Mahler; Tai Yi; Jay D Humphrey; Jed Johnson; Christopher K Breuer; Narutoshi Hibino
Journal:  Tissue Eng Part A       Date:  2018-05-10       Impact factor: 3.845

10.  Promoting Endothelial Cell Affinity and Antithrombogenicity of Polytetrafluoroethylene (PTFE) by Mussel-Inspired Modification and RGD/Heparin Grafting.

Authors:  Hao-Yang Mi; Xin Jing; James A Thomsom; Lih-Sheng Turng
Journal:  J Mater Chem B       Date:  2018-05-09       Impact factor: 6.331

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.